Pulse Biosciences, Inc. Increase (Decrease) in Deferred Charges
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Deferred Charges of $280.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2018-03-16
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for the quarter ending 2016-12-31 was $67.00K, a 77.96% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for the quarter ending 2016-09-30 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for the quarter ending 2016-06-30 was $67.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for the quarter ending 2016-03-31 was $146.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for fiscal 2016 was $280.00K, a 19.31% decline from fiscal 2015.
- Pulse Biosciences, Inc. increase (decrease) in deferred charges for fiscal 2015 was $347.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2016-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $67.00K derived: sum of 2 quarters · filed 2018-03-16 | $134.00K derived: sum of 3 quarters · filed 2018-03-16 | $280.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $67.00K derived: sum of 2 quarters · filed 2016-11-14 | $213.00K 10-Q · filed 2016-11-14 | $517.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $213.00K 10-Q · filed 2016-08-10 | $517.00K derived: sum of 3 quarters · filed 2018-03-16 | |
| 2016-03-31 | $146.00K 10-Q · filed 2017-05-10 | $450.00K derived: sum of 2 quarters · filed 2018-03-16 | ||
| 2015-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $347.00K 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $43.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |